| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.318 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.170 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.161 | |
| male gamete generation | GO:0048232 | 285 | 0.160 | |
| renal inner medulla development | GO:0072053 | 3 | 0.153 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.153 | |
| endocrine system development | GO:0035270 | 98 | 0.141 | |
| renal outer medulla development | GO:0072054 | 2 | 0.137 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.137 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.136 | |
| maintenance of cell number | GO:0098727 | 3 | 0.130 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.129 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.118 | |
| membrane organization | GO:0061024 | 245 | 0.115 | |
| spermatogenesis | GO:0007283 | 284 | 0.114 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.114 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.112 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.112 | |
| embryonic placenta development | GO:0001892 | 98 | 0.110 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.110 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.108 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.107 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.106 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.105 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.104 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.104 | |
| cardiac chamber development | GO:0003205 | 108 | 0.103 | |
| regulation of anagen | GO:0051884 | 1 | 0.103 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.102 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.101 | |
| cation transport | GO:0006812 | 399 | 0.101 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.100 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.099 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.097 | |
| fertilization | GO:0009566 | 127 | 0.097 | Mouse |
| hindbrain formation | GO:0021576 | 1 | 0.097 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.097 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.096 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.096 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.094 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.093 | |
| synaptic transmission | GO:0007268 | 329 | 0.093 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.092 | |
| gas homeostasis | GO:0033483 | 3 | 0.091 | |
| stem cell differentiation | GO:0048863 | 268 | 0.088 | |
| protein maturation | GO:0051604 | 176 | 0.088 | |
| ossification | GO:0001503 | 216 | 0.087 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.087 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.087 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.087 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.087 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.086 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.086 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.085 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.084 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.084 | |
| cerebellum formation | GO:0021588 | 1 | 0.084 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.084 | |
| heart morphogenesis | GO:0003007 | 178 | 0.083 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.082 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.082 | |
| metanephros development | GO:0001656 | 79 | 0.081 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.081 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.080 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.079 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.079 | |
| amine metabolic process | GO:0009308 | 45 | 0.078 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.078 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.077 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.077 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.077 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.076 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.076 | |
| respiratory system development | GO:0060541 | 190 | 0.075 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.075 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.074 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.073 | |
| skeletal system development | GO:0001501 | 356 | 0.073 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.071 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.071 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.071 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.071 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.070 | |
| kidney development | GO:0001822 | 213 | 0.070 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.070 | |
| digestive tract development | GO:0048565 | 190 | 0.070 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.069 | |
| mesoderm development | GO:0007498 | 100 | 0.068 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.068 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.066 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.066 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.066 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.066 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.066 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.066 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.065 | |
| organelle fission | GO:0048285 | 170 | 0.065 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.064 | |
| connective tissue development | GO:0061448 | 179 | 0.064 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.063 | |
| positive regulation of smoothened signaling pathway | GO:0045880 | 23 | 0.062 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.062 | |
| placenta development | GO:0001890 | 140 | 0.061 | |
| epithelial cell migration | GO:0010631 | 63 | 0.061 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.061 | |
| oviduct development | GO:0060066 | 3 | 0.060 | |
| protein processing | GO:0016485 | 163 | 0.060 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.060 | |
| pallium development | GO:0021543 | 120 | 0.059 | |
| protein catabolic process | GO:0030163 | 221 | 0.059 | |
| gastrulation | GO:0007369 | 116 | 0.058 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.058 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.058 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.057 | |
| cerebral cortex development | GO:0021987 | 86 | 0.057 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.057 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.057 | |
| metanephric capsule specification | GO:0072267 | 1 | 0.056 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.056 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.056 | |
| telencephalon development | GO:0021537 | 186 | 0.056 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.056 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.055 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.055 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.055 | |
| metencephalon development | GO:0022037 | 89 | 0.054 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.054 | |
| lung development | GO:0030324 | 164 | 0.054 | |
| spemann organizer formation | GO:0060061 | 2 | 0.054 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.054 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.052 | |
| dna metabolic process | GO:0006259 | 303 | 0.052 | |
| nephron development | GO:0072006 | 109 | 0.052 | |
| negative regulation of neuron projection regeneration | GO:0070571 | 3 | 0.051 | |
| developmental cell growth | GO:0048588 | 84 | 0.051 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.051 | |
| response to growth factor | GO:0070848 | 198 | 0.051 | |
| respiratory tube development | GO:0030323 | 167 | 0.051 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.050 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.050 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.050 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.050 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.050 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.050 | |
| lung induction | GO:0060492 | 3 | 0.049 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.049 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.049 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.049 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.049 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.048 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.048 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.048 | |
| pituitary gland development | GO:0021983 | 38 | 0.048 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.048 | |
| nephron tubule development | GO:0072080 | 84 | 0.048 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.047 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.047 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.047 | |
| cellular homeostasis | GO:0019725 | 240 | 0.047 | |
| mapk cascade | GO:0000165 | 281 | 0.047 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.047 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.047 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.047 | |
| skin development | GO:0043588 | 220 | 0.046 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.046 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.046 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.045 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.045 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.045 | |
| regulation of cell size | GO:0008361 | 72 | 0.045 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.045 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.045 | |
| somatic sex determination | GO:0018993 | 2 | 0.044 | |
| morphogenesis of an epithelial fold | GO:0060571 | 28 | 0.044 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.044 | |
| regionalization | GO:0003002 | 337 | 0.044 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.044 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.044 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.044 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.044 | |
| regulation of wound healing | GO:0061041 | 40 | 0.043 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.043 | |
| circulatory system process | GO:0003013 | 197 | 0.043 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.043 | |
| spermatid development | GO:0007286 | 108 | 0.043 | |
| neuron projection guidance | GO:0097485 | 141 | 0.042 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.042 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.042 | |
| nuclear division | GO:0000280 | 158 | 0.041 | |
| ear development | GO:0043583 | 200 | 0.041 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.041 | |
| appendage development | GO:0048736 | 166 | 0.041 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.040 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.040 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.040 | |
| anatomical structure regression | GO:0060033 | 9 | 0.040 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.040 | |
| cartilage development | GO:0051216 | 140 | 0.040 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.040 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.040 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.040 | |
| germ cell development | GO:0007281 | 185 | 0.039 | |
| muscle system process | GO:0003012 | 141 | 0.038 | |
| ectoderm formation | GO:0001705 | 3 | 0.038 | |
| regulation of secretion | GO:0051046 | 274 | 0.038 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.038 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.038 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.038 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.038 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.038 | |
| cerebral cortex radial glia guided migration | GO:0021801 | 17 | 0.037 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.037 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.037 | |
| tube formation | GO:0035148 | 140 | 0.037 | |
| protein localization to membrane | GO:0072657 | 108 | 0.037 | |
| microtubule based process | GO:0007017 | 236 | 0.037 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.037 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.036 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.036 | |
| foregut regionalization | GO:0060423 | 3 | 0.036 | |
| renal tubule development | GO:0061326 | 87 | 0.036 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.036 | |
| renal capsule specification | GO:0072130 | 1 | 0.036 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.036 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.036 | |
| urogenital system development | GO:0001655 | 261 | 0.036 | |
| blastocyst development | GO:0001824 | 80 | 0.036 | |
| stem cell proliferation | GO:0072089 | 117 | 0.036 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.035 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.035 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.035 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.035 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.035 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.035 | |
| notch signaling pathway | GO:0007219 | 71 | 0.035 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.035 | |
| mesoderm formation | GO:0001707 | 62 | 0.035 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.035 | |
| digestive system development | GO:0055123 | 200 | 0.035 | |
| axonogenesis | GO:0007409 | 274 | 0.035 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.035 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.035 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.034 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.034 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.034 | |
| pancreas development | GO:0031016 | 57 | 0.034 | |
| hindbrain development | GO:0030902 | 128 | 0.034 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.034 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.033 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.033 | |
| interleukin 8 production | GO:0032637 | 4 | 0.033 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.033 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.033 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.033 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.033 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.033 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.033 | |
| white fat cell proliferation | GO:0070343 | 2 | 0.033 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.032 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.032 | |
| extracellular structure organization | GO:0043062 | 148 | 0.032 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.032 | |
| muscle tissue development | GO:0060537 | 308 | 0.032 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.032 | |
| epithelial tube formation | GO:0072175 | 130 | 0.032 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.032 | |
| stem cell maintenance | GO:0019827 | 130 | 0.032 | |
| regulation of ossification | GO:0030278 | 112 | 0.032 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.032 | |
| regulation of cell activation | GO:0050865 | 289 | 0.032 | |
| kidney epithelium development | GO:0072073 | 121 | 0.032 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.032 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.032 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.032 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.032 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.031 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.031 | |
| epidermis development | GO:0008544 | 187 | 0.031 | |
| cytokine production | GO:0001816 | 319 | 0.031 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.031 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.031 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.031 | |
| renal system development | GO:0072001 | 225 | 0.031 | |
| female somatic sex determination | GO:0019101 | 1 | 0.031 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.031 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.030 | |
| calcium ion transport | GO:0006816 | 159 | 0.030 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.030 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.030 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.030 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.030 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.030 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.030 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.030 | |
| neuron projection extension | GO:1990138 | 64 | 0.030 | |
| female sex determination | GO:0030237 | 1 | 0.030 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.030 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.030 | |
| regulation of vascular wound healing | GO:0061043 | 2 | 0.030 | |
| synapse organization | GO:0050808 | 125 | 0.030 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.030 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.030 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.030 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.030 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.029 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.029 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.029 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.029 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.029 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.029 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.029 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.029 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.029 | |
| male sex differentiation | GO:0046661 | 109 | 0.029 | |
| prostate gland development | GO:0030850 | 48 | 0.029 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.029 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.029 | |
| gland development | GO:0048732 | 330 | 0.029 | Fly |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.029 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.029 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.029 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.029 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.028 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.028 | |
| forebrain development | GO:0030900 | 302 | 0.028 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.028 | |
| cell maturation | GO:0048469 | 127 | 0.028 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.028 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.028 | |
| regulation of axon diameter | GO:0031133 | 6 | 0.028 | |
| regulation of cell growth | GO:0001558 | 91 | 0.028 | |
| cerebral cortex radially oriented cell migration | GO:0021799 | 31 | 0.028 | |
| neuromuscular process | GO:0050905 | 99 | 0.028 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.027 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.027 | |
| regulation of protein processing | GO:0070613 | 96 | 0.027 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.027 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.027 | |
| hippocampus development | GO:0021766 | 52 | 0.027 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.027 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.027 | |
| regulation of tube size | GO:0035150 | 57 | 0.027 | |
| stem cell development | GO:0048864 | 219 | 0.027 | |
| gliogenesis | GO:0042063 | 141 | 0.026 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.026 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.026 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.026 | |
| multicellular organism growth | GO:0035264 | 161 | 0.026 | |
| nephric duct formation | GO:0072179 | 4 | 0.026 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 15 | 0.026 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.026 | |
| female sex differentiation | GO:0046660 | 84 | 0.026 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.026 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.026 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.026 | |
| cell growth | GO:0016049 | 130 | 0.026 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.026 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.026 | |
| muscle contraction | GO:0006936 | 101 | 0.026 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.026 | |
| developmental maturation | GO:0021700 | 193 | 0.026 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.025 | |
| specification of organ identity | GO:0010092 | 30 | 0.025 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.025 | |
| ureteric bud development | GO:0001657 | 94 | 0.025 | |
| regeneration | GO:0031099 | 38 | 0.025 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.025 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.025 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.025 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.025 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.025 | |
| neurotransmitter secretion | GO:0007269 | 62 | 0.025 | |
| tongue development | GO:0043586 | 18 | 0.025 | |
| fat cell differentiation | GO:0045444 | 160 | 0.025 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.025 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.025 | |
| epithelium migration | GO:0090132 | 63 | 0.025 | |
| angiogenesis | GO:0001525 | 201 | 0.025 | |
| male gonad development | GO:0008584 | 88 | 0.025 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.025 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.025 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.025 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.025 | |
| chromatin organization | GO:0006325 | 206 | 0.024 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.024 | |
| negative regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902257 | 2 | 0.024 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.024 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.024 | |
| axon guidance | GO:0007411 | 141 | 0.024 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.024 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.024 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.024 | |
| learning or memory | GO:0007611 | 148 | 0.024 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.024 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.024 | |
| tissue homeostasis | GO:0001894 | 115 | 0.024 | |
| metanephric nephron development | GO:0072210 | 34 | 0.024 | |
| cell adhesion | GO:0007155 | 329 | 0.024 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.024 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.024 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.024 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.024 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.024 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.024 | |
| renal vesicle induction | GO:0072034 | 3 | 0.024 | |
| ear morphogenesis | GO:0042471 | 118 | 0.023 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.023 | |
| nephron epithelium development | GO:0072009 | 92 | 0.023 | |
| olfactory lobe development | GO:0021988 | 32 | 0.023 | |
| positive regulation of growth | GO:0045927 | 104 | 0.023 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.023 | |
| regulation of organ growth | GO:0046620 | 61 | 0.023 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.023 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.023 | Fly |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.023 | |
| metanephric capsule morphogenesis | GO:0072265 | 1 | 0.023 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.023 | |
| metanephric capsule formation | GO:0072266 | 1 | 0.023 | |
| adenohypophysis development | GO:0021984 | 14 | 0.023 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.023 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.023 | |
| bone mineralization | GO:0030282 | 54 | 0.023 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.023 | |
| tissue migration | GO:0090130 | 68 | 0.023 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.023 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.023 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.023 | |
| neuron death | GO:0070997 | 154 | 0.023 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.023 | |
| cervix development | GO:0060067 | 2 | 0.022 | |
| transmembrane transport | GO:0055085 | 412 | 0.022 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.022 | |
| organelle localization | GO:0051640 | 179 | 0.022 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.022 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.022 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.022 | |
| chemotaxis | GO:0006935 | 247 | 0.022 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.022 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.022 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.022 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.022 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.022 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.022 | |
| blood circulation | GO:0008015 | 195 | 0.022 | |
| hair follicle development | GO:0001942 | 85 | 0.022 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.022 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.022 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.022 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.022 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.022 | |
| detection of stimulus | GO:0051606 | 84 | 0.021 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.021 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.021 | |
| renal capsule formation | GO:0072129 | 1 | 0.021 | |
| paraxial mesoderm morphogenesis | GO:0048340 | 10 | 0.021 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.021 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.021 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.021 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.021 | |
| spleen development | GO:0048536 | 39 | 0.021 | |
| cellular response to starvation | GO:0009267 | 57 | 0.021 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.021 | |
| cerebellum development | GO:0021549 | 77 | 0.021 | |
| epithelial cell development | GO:0002064 | 159 | 0.021 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.021 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.021 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.021 | |
| negative regulation of transcription by glucose | GO:0045014 | 1 | 0.021 | |
| developmental induction | GO:0031128 | 34 | 0.021 | |
| regulation of metanephros development | GO:0072215 | 15 | 0.021 | |
| lung field specification | GO:0060424 | 3 | 0.021 | |
| camera type eye development | GO:0043010 | 266 | 0.021 | |
| detection of monosaccharide stimulus | GO:0034287 | 1 | 0.021 | |
| primary neural tube formation | GO:0014020 | 95 | 0.020 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.020 | |
| jnk cascade | GO:0007254 | 72 | 0.020 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.020 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.020 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.020 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.020 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.020 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.020 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.020 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.020 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.020 | |
| spinal cord development | GO:0021510 | 81 | 0.020 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.020 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.020 | |
| striated muscle cell development | GO:0055002 | 125 | 0.020 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.020 | |
| oocyte differentiation | GO:0009994 | 35 | 0.020 | |
